Our founders

Built at the intersection
of discovery and execution.

We share one conviction: understanding which cells cause harm is the first step toward protecting the heart with precision.

Portrait of the founder and chief executive officerAnis Hanna, MD

Founder & Chief Executive Officer

A cardiovascular physician-scientist and computational biologist focused on the mechanisms that drive heart failure after myocardial infarction.

His research brings together cardiovascular spatial omics, single-cell analysis, and experimental models to distinguish protective repair from harmful fibrosis at the scar border.

A research assistant professor in a post-infarction heart failure laboratory and recipient of multiple American Heart Association awards, he leads the scientific and translational vision of CorPhylaxis.

Albert Einstein College of Medicine · UC San DiegoCardiovascular research · Wilf Family Cardiovascular Research Institute
Portrait of the founder and chief operating officerPolina Alieva

Founder & Chief Operating Officer

A single-cell and spatial biology specialist with deep industry experience managing and scaling wet-lab genomics operations.

Her expertise connects high-resolution target discovery with the practical systems, teams, and processes required to deliver reproducible research at scale.

As a genomics operational manager, she brings the operating discipline needed to translate complex biological insights into a focused development program.

SingulomicsGenomics operations and spatial biology

Scientific and operational experience built in leading research environments.

Albert Einstein College of MedicineUC San DiegoSingulomics
A new future for the healing heart

Invest in the future of
heart failure gene therapy.

We are happy to discuss. Let’s move the science forward, together.

Start a conversation